Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 19:11:623072.
doi: 10.3389/fimmu.2020.623072. eCollection 2020.

Total Recall: Intestinal TRM Cells in Health and Disease

Affiliations
Review

Total Recall: Intestinal TRM Cells in Health and Disease

Eva-Maria Paap et al. Front Immunol. .

Abstract

Tissue-resident memory T cells (TRM cells) have crucial functions in host defense in mucosal tissues. They provide local adaptive immune surveillance and allow the fast initiation of targeted adaptive immune responses in case of antigen re-exposure. Recently, an aberrant activation in the case of immunologically mediated diseases has been increasingly acknowledged. As the organ with the largest interface to the environment, the gastrointestinal tract faces billions of antigens every day. Tightly balanced processes are necessary to ensure tolerance towards non-hazardous antigens, but to set up a powerful immune response against potentially dangerous ones. In this complex nexus of immune cells and their mediators, TRM cells play a central role and have been shown to promote both physiological and pathological events. In this review, we will summarize the current knowledge on the homeostatic functions of TRM cells and delineate their implication in infection control in the gut. Moreover, we will outline their commitment in immune dysregulation in gastrointestinal chronic inflammatory conditions and shed light on TRM cells as current and potential future therapeutic targets.

Keywords: infection control; inflammatory bowel diseases; intestine; therapeutic targets; tissue-resident memory T cells.

PubMed Disclaimer

Conflict of interest statement

SZ and MN received research support from Takeda, Roche, and Shire. MN has served as an advisor for Pentax, Giuliani, MSD, Abbvie, Janssen, Takeda, and Boehringer. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Profile and function of TRM cells. Left side: TRM cells develop during primary infection. The differentiation and maintenance of TRM cells is controlled by tissue-derived signals, e.g., TNF-α, TGF-β or IL-15 and IL-33 resulting in the up- and down-regulation of different genes via activity of the transcription factors Hobit, Blimp-1, Runx3, and Notch and the silencing of Klf2. In particular, upregulation of CD69 and CD103 and simultaneous downregulation of S1PR1 are key drivers of TRM cell tissue retention. Other membrane molecules highly expressed in TRM cells are CD49a, CD101, PD-1, CRTAM, and CXCR6 while CD62L, CCR7, and CX3CR1 show a decreased expression pattern in TRM cells. Right side: After re-exposure to a cognate antigen (e.g., from a pathogen, shown in purple), TRM cells are able to initiate a fast immune response. This includes chemokine release to recruit lymphocytes (indicated as red, orange, and blue immune cells) to the site of infection, release of pro-inflammatory cytokines (IFN-γ, TNF-α) to activate other cells as well as the production of the cytotoxic effectors perforin or granzyme B. There is also evidence for the ability of TRM cells to proliferate or to re-differentiate (indicated as green and orange cells) and to leave the tissue (orange ex-TRM cells; for details cf. main text). TRM, tissue-resident memory T cell; TNF, tumor necrosis factor; TGF, transforming growth factor; IL, Interleukin; KLF, Krüppel-like factor; CD, cluster of differentiation; S1PR1, sphingosine-1-phosphate receptor 1; PD-1, programmed cell death protein 1; CRTAM, cytotoxic and regulatory T-cell molecule; CXCR, CXC-motif chemokine receptor; CCR, Chemokine receptor.

References

    1. Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature (1999) 402(6763):34–8. 10.1038/35005534 - DOI - PubMed
    1. Masopust D, Choo D, Vezys V, Wherry EJ, Duraiswamy J, Akondy R, et al. Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med (2010) 207(3):553–64. 10.1084/jem.20090858 - DOI - PMC - PubMed
    1. Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, Harmsen AG, et al. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol (2001) 166(3):1813–22. 10.4049/jimmunol.166.3.1813 - DOI - PubMed
    1. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol (2009) 10(5):524–30. 10.1038/ni.1718 - DOI - PubMed
    1. Park SL, Zaid A, Hor JL, Christo SN, Prier JE, Davies B, et al. Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses. Nat Immunol (2018) 19(2):183–91. 10.1038/s41590-017-0027-5 - DOI - PubMed

Publication types